File pursuant to Rule 424(b)(7)
Registration No. 333-141605

PROSPECTUS SUPPLEMENT NO. 6

(To prospectus dated March 27, 2007)

1,819,582 Shares

Ventas, Inc.

Common Stock

 

---

This prospectus supplement no. 6, which supplements the prospectus filed by us on March 27, 2007, as supplemented on April 11, 2007, May 14, 2007, June 12, 2007, July 2, 2007 and August 10, 2007, relates to the resale from time to time by selling stockholders of the shares of common stock that may be issued to them upon the conversion of our 3 ⁷/8% Convertible Senior Notes due 2011.

You should read this prospectus supplement in conjunction with the related prospectus, including any amendments or supplements thereto, which should be delivered in conjunction with this prospectus supplement. This prospectus supplement is not complete without, and may not be delivered or used except in conjunction with the prospectus, including any such amendments or supplements. This prospectus supplement is qualified by reference to the prospectus, as previously supplemented, except to the extent that the information provided by this prospectus supplement supercedes information contained in the prospectus, as previously supplemented.

You should read and rely only on the information contained in this prospectus supplement and the related prospectus, as previously supplemented, together with additional information described on page 8 of the related prospectus under the heading “Where You Can Find More Information and Incorporation by Reference.” Neither we nor the selling stockholders have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor the selling stockholders are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information contained or incorporated by reference in this prospectus supplement or the related prospectus, as previously supplemented, is accurate only as of the date of the documents containing the information.

Investing in our common stock involves risks. See “Risk Factors” beginning on page 1 of the related prospectus.

 

---

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities or passed upon the accuracy or adequacy of this prospectus supplement or the related prospectus. Any representation to the contrary is a criminal offense.

 

---

The date of this prospectus supplement is August 31, 2007.

---

The information appearing under the heading “Selling Stockholders” beginning on page 3 of the related prospectus, as previously supplemented, is amended and restated in its entirety by the information below.

SELLING STOCKHOLDERS

Our 3 ⁷/8% Convertible Senior Notes due 2011 (the “notes”) were originally issued by us to and immediately resold by Banc of America Securities LLC and J.P. Morgan Securities, Inc. in transactions exempt from the registration requirements of the Securities Act to persons reasonably believed by the initial purchasers to be “qualified institutional buyers” as defined by Rule 144A under the Securities Act. Selling stockholders, including their transferees, pledgees, donees and successors, may from time to time offer and sell pursuant to this prospectus and any accompanying prospectus supplement any or all of the shares of our common stock that we may issue upon the conversion of the notes.

The table below sets forth the name of each selling stockholder and the number of shares of our common stock that would become beneficially owned by each selling stockholder should we issue our common stock that may be offered pursuant to this prospectus upon conversion of the notes. We have prepared the table below based on information provided to us by or on behalf of the selling stockholders on or prior to August 30, 2007. The selling stockholders may offer all, some or none of the shares of our common stock that we may issue upon the conversion of the notes. Accordingly, we cannot estimate the number of shares of our common stock that will be held by the selling stockholders upon consummation of any of these sales. In addition, the selling stockholders identified below may have acquired, sold, transferred or otherwise disposed of, in transactions exempt from the registration requirements of the Securities Act, all or a portion of their notes or shares of our common stock since the date on which they provided the information regarding their notes.

The number of shares of our common stock issuable upon the conversion of the notes shown in the table below assumes conversion of the full amount of notes held by each selling stockholder at the initial conversion rate of 22.1867 shares of our common stock per $1,000 principal amount of notes and a cash payment in lieu of any fractional share, assuming 10% annual growth in our dividend rate and 25% quarterly growth in the market price of our common stock. Effective June 14, 2007, the conversion rate was adjusted to 22.2736 shares per $1,000 principal amount of notes and is subject to further adjustment in certain events. Accordingly, the number of shares of our common stock issued upon the conversion of the notes may increase or decrease from time to time. The number of shares of our common stock owned by the other selling stockholders or any future transferee from any such holder assumes that they do not beneficially own any shares of common stock other than the common stock that we may issue to them upon the conversion of the notes.

Based upon information provided by the selling stockholders, none of the selling stockholders or their affiliates has, or within the past three years has had, any material relationship with us or any of our predecessors or affiliates.

To the extent any of the selling stockholders identified below are broker-dealers, they may be deemed to be, under interpretations of the staff of the Commission, “underwriters” within the meaning of the Securities Act.

Information about the selling stockholders may change over time. Any changed information will be set forth in supplements to this prospectus, if required.

 

Name of Selling Stockholder		Principal Amount of Notes Owned Prior to Offering			Number of Shares Beneficially Owned Prior to Offering		Number of Shares Being Offered		Number of Shares Beneficially Owned After Offering (1)		Percentage of Shares Outstanding (1)(2)
Advent Convertible Arb Master		$	4,558,000		36,059		36,059		—		*
Alcon Laboratories			493,000		3,900		3,900		—		*
Aristeia International Limited			9,900,000		78,320		78,320		—		*
Aristeia Partners LP			10,100,000		79,903		79,903		—		*

 

S-1

---

Name of Selling Stockholder		Principal Amount of Notes Owned Prior to Offering		Number of Shares Beneficially Owned Prior to Offering		Number of Shares Being Offered		Number of Shares Beneficially Owned After Offering (1)		Percentage of Shares Outstanding (1)(2)
Arlington County Employees Retirement System		707,000		5,593		5,593		—		*
BNP Paribas Arbitrage (3)		2,000,000		15,822		15,822		—		*
British Virgin Islands Social Security Board		163,000		1,289		1,289		—		*
Canyon Capital Arbitrage Master Fund, Ltd. (4)		2,720,000		21,518		21,518		—		*
Canyon Value Realization Fund, L.P. (4)		1,440,000		11,392		11,392		—		*
Canyon Value Realization MAC 18 Ltd. (4)		160,000		1,265		1,265		—		*
CQS Convertible and Quantitative Strategies Master Fund Limited		11,500,000		90,978		90,978		—		*
Credit Industriel Et Commercial		2,500,000		19,777		19,777		—		*
Domestic & Foreign Missionary Society – DFMS		92,000		727		727		—		*
FFVA Mutual Insurance Company		45,000		356		356		—		*
Florida Fruit & Vegetable Association		69,000		545		545		—		*
Georgia Municipal Employee Benefit System		985,000		7,792		7,792		—		*
GLG Market Neutral Fund		20,000,000		158,224		158,224		—		*
GMIMCO Trust		500,000		3,955		3,955		—		*
Grady Hospital Foundation		135,000		1,068		1,068		—		*
Highbridge Convertible Arbitrage Master Fund LP		5,000,000		39,556		39,556		—		*
Highbridge International LLC		15,000,000		118,668		118,668		—		*
HFR CA Opportunity Master Trust		232,000		1,835		1,835		—		*
Independence Blue Cross		561,000		4,438		4,438		—		*
KBC Financial Products USA Inc. (5)		7,000,000		55,378		55,378		—		*
LDG Limited		222,000		1,756		1,756		—		*
Linden Capital LP		5,000,000		39,556		39,556		—		*
Luxor/Canyon Capital Arbitrage Fund Ltd. (4)		2,000,000		15,822		15,822		—		*
Lyxor Master Trust Fund		210,000		1,661		1,661		—		*
MSS Convertible Arbitrage 1 Fund c/o TQA Investors, LLC		49,000		387		387		—		*
Occidental Petroleum Corporation		317,000		2,507		2,507		—		*
Old Lane Cayman Master Fund LP		526,000		4,161		4,161		—		*
Old Lane HMA Master Fund LP		102,000		806		806		—		*
Old Lane U.S. Master Fund LP		172,000		1,360		1,360		—		*
Pro Mutual		894,000		7,072		7,072		—		*
Redbrick Capital Master Fund LTD		24,500,000		193,824		193,824		—		*
S.A.C. Arbitrage Fund, LLC		6,500,000		51,422		51,422		—		*
San Francisco City & County ERS		1,400,000		11,075		11,075		—		*
Silvercreek Limited Partnership		6,600,000		52,213		52,213		—		*
Silvercreek II Limited		4,400,000		34,809		34,809		—		*
Tamalpais Asset Management, L.P .		10,000,000		79,112		79,112		—		*

 

S-2

---

Name of Selling Stockholder		Principal Amount of Notes Owned Prior to Offering			Number of Shares Beneficially Owned Prior to Offering		Number of Shares Being Offered		Number of Shares Beneficially Owned After Offering (1)		Percentage of Shares Outstanding (1)(2)
The Canyon Value Realization Fund (Cayman), Ltd. (4)			3,680,000		29,113		29,113		—		*
The City University of New York			141,000		1,115		1,115		—		*
The Grable Foundation			65,000		514		514		—		*
The Police & Fire Retirement System of the City of Detroit			418,000		3,306		3,306		—		*
TQA Master Fund, Ltd.			1,421,000		11,241		11,241		—		*
TQA Master Plus Fund, Ltd			815,000		6,447		6,447		—		*
Trustmark Insurance Company			266,000		2,104		2,104		—		*
UBS O’Connor LLC f/b/o O’Connor Global Convertible Arbitrage Master Limited			6,820,000		53,954		53,954		—		*
UBS O’Connor LLC f/b/o O’Connor Global Convertible Arbitrage II Master Limited			680,000		5,379		5,379		—		*
Vicis Capital Master Fund			4,000,000		31,644		31,644		—		*
Waterstone Market Neutral Mac 51 Fund, Ltd.			6,222,000		49,223		49,223		—		*
Waterstone Market Neutral Master Fund, Ltd.			11,778,000		93,178		93,178		—		*
Zurich Institutional Benchmarks Master Fund Ltd c/o TQA Investors, LLC			542,000		4,287		4,287		—		*
Total (6)		$	195,600,000

---

*	Less than 1%.

 

(1)

The beneficial ownership in this column assumes that the selling stockholder sells all of the shares offered by this prospectus that are beneficially owned by the selling stockholder and that prior to the sale of such shares the selling stockholder does not acquire additional shares or dispose of shares beneficially owned by the stockholder that are not being offered pursuant to this prospectus.

 

(2)	The percentage of outstanding shares is based on 133,392,112 shares of common stock outstanding as of August 1, 2007.

 

(3)	The selling stockholder is under common ownership with BNP Paribas Securities Corp., a registered broker-dealer.

 

(4)

The selling stockholder’s investment advisor, Canyon Capital Advisors, LLC, is under common ownership with Canyon Partners Incorporated, a registered broker-dealer. The selling stockholder has reported an open short position in our common stock as follows: Canyon Capital Arbitrage Master Fund, Ltd. – 30,859 shares; Canyon Value Realization Fund, L.P. – 16,337 shares; Canyon Value Realization MAC 18 Ltd. – 1,815 shares; Luxor/Canyon Capital Arbitrage Fund Ltd. – 20,487 shares; and The Canyon Value Realization Fund (Cayman), Ltd. – 37,702 shares.

 

(5)	The selling stockholder is a registered broker-dealer and consents to being named as an underwriter.

 

(6)

Additional selling stockholders not named in this prospectus will not be able to use this prospectus for resales until they are named in the table above by prospectus supplement or post-effective amendment. Transferees, successors and donees of identified selling stockholders will not be able to use this prospectus for resales until they are named in the table above by prospectus supplement or post-effective amendment. If required, we will add transferees, successors and donees by prospectus supplement in instances where the transferee, successor or donee has acquired its shares from holders named in this prospectus after the effective date of this prospectus.

 

S-3